Glympse Bio Inc.

First-In-Human Data Supporting the Safety of Glympse Bio's ...

PRNewswire/ -- Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood, tracked, and treated, ...

Sunbird: blood-based diagnostics via exosomes and proteases

Ltd., a Singaporean company backed by ClavystBio, Polaris Partners and Section 32, and Glympse ... Sunbird Bio Inc. Temasek. BCIQ Target Profiles.

Glympse Bio Secures $46.7 Million Series B Financing - ISPE Boston

In addition to the NASH studies, the Series B funding will support further development of the company's oncology program and initiate ...

Gilead and Glympse Bio Announce Strategic Collaboration for Use ...

Gilead Sciences Inc. (Nasdaq: GILD) and Glympse Bio, Inc., today announced that the companies have entered into a strategic collaboration in ...

Matthew Navarro - Glympse Bio - LinkedIn

Experience: Glympse Bio · Education: University of North Carolina at Chapel Hill · Location: Raleigh-Durham-Chapel Hill Area · 313 connections on LinkedIn.

Tunable Biosensors for Noninvasive Disease Monitoring - YouTube

Dr. Caroline Loew, President and CEO of Glympse Bio, a clinical stage biotechnology company, discusses the company's development of tunable ...

Glympse diagnostic detects HCC in blood - BioWorld

Glympse Bio Inc.'s diagnostic platform has demonstrated the ability to detect hepatocellular carcinoma (HCC) in blood, ...

Glympse Bio, Inc. SBIR Phase I Award, June 2019 | Golden

A SBIR Phase I contract was awarded to Glympse Bio in June, 2019 for $291191.0 USD from the U.S. Department of Health & Human Services and ...

Gilead Sciences : Glympse Bio Raises $46.7 Million in Series B ...

The Cambridge, Mass., company founded in 2015 has now raised $75.3 million. Glympse said it will use the new funding to support continued ...

Glympse Bio Funding Round - Gaebler Ventures

Glympse Bio is pioneering an in vivo sensing technology dedicated to transforming disease monitoring. The company has built a product engine ...

CA-GILEAD-SCIENCES-INC. | Business Wire

Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development.

SunBird Bio, Inc. - fund raising filing - FormDs.com

SunBird Bio, Inc. - Most recent fund raising on May 12, 2023 raised $23239099 in Equity.

Global Drug Intelligence Database - Patsnap Synapse

Glympse Bio, Inc. Startup. Drug Highest Phase. PendingPhase ... Glympse Glympse is a biotechnology company focused on optimizing disease diagnosis and monitoring.

Glympse Bio: Revenue, Competitors, Alternatives

Glympse Bio, a Cambridge, Mass.-based biotechnology company, closed a $46.7m Series B financing. The round was led by Section 32 and includes new investors ...

Codiak, Glympse Bio Expand To Davis Companies' Alewife Lab

Ltd., the Japanese pharmaceutical development partner of Cambridge-based Biogen (Nasdaq: BIIB); genetic expression biotech Syros Pharmaceuticals (Nasdaq ...

Asia Digest: Glympse buys Sunbird Bio; SBI joins Zodia round

US-based Glympse Bio, Inc has acquired Singapore-based Sunbird Bio while Zodia Custody has raised Series A funding.

SEC FORM D/A

c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100. City, State/Province/Country, ZIP/PostalCode. Cambridge, MASSACHUSETTS, 02140 ...

Early detection of HCC using noninvasive activity-based nanosensors

Glympse Bio, Inc., Cambridge, MA, United States. Search 5 grants from Wendy Winckler · Search grants from Glympse Bio, Inc. Share this grant: LinkedIn ...

Gilead and Glympse partner on biomarker technology use

Glympse Bio Inc · View all. These biomarkers are bioengineered to identify disease progression and stage, as well as early detection of ...

Gilead and Glympse partner in clinical development for NASH

Glympse Bio Inc · View all. The technology has been developed for a range of complex disease, including cancer, inflammatory conditions and ...